loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Pirepemat

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Pirepemat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IRLAB Granted Patent For Pirepemat Expanding Patent Protection In The US
    IRLAB Granted Patent For Pirepemat Expanding Patent Protection In The US

    18 Sep 2024

    // ACCESSWIRE

    https://www.accesswire.com/919554/irlab-granted-additional-patent-for-its-drug-candidate-pirepemat-expanding-the-patent-protection-in-the-us

    ACCESSWIRE
    18 Sep 2024
    Share Share
    IRLAB's Phase IIb Study Of Pirepemat Proceeds After Positive Safety Review
    IRLAB's Phase IIb Study Of Pirepemat Proceeds After Positive Safety Review

    02 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=884181&lang=en

    ACCESSWIRE
    02 Jul 2024
    Share Share
    IRLAB’s Phase IIb Study with Pirepemat - React-PD - Provides New Insights
    IRLAB’s Phase IIb Study with Pirepemat - React-PD - Provides New Insights

    06 Feb 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=831422&lang=en

    ACCESSWIRE
    06 Feb 2024
    Share Share
    IRLAB is Granted Additional Patent for Drug Candidate Pirepemat
    IRLAB is Granted Additional Patent for Drug Candidate Pirepemat

    12 Dec 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=815915&lang=en

    ACCESSWIRE
    12 Dec 2023
    Share Share